Australia’s CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has commenced its Phase 2A pilot dose determination study for its …
Australia’s CannPal Animal Therapeutics Limited (ASX:CP1) has announced it has commenced its Phase 2A pilot dose determination study for its …